A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis

BACKGROUND: Interleukin 12 (IL-12), a cytokine that promotes generation of helper T cells subtype 1, is increased in multiple sclerosis. Albuterol sulfate, a β2-adrenergic agonist, reduces IL-12 expression, so we tested the effect of albuterol as an add-on treatment to glatiramer acetate therapy. OB...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khoury, Samia J., Healy, Brian C., Kivisäkk, Pia, Viglietta, Vissia, Egorova, Svetlana, Guttmann, Charles R. G., Wedgwood, Josiah F., Hafler, David A., Weiner, Howard L., Buckle, Guy, Cook, Sandra, Reddy, Susheel
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954052/
https://ncbi.nlm.nih.gov/pubmed/20837847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2010.222
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados